Performance of HbA1c for detecting newly diagnosed diabetes and pre-diabetes in Chinese communities living in Beijing

Diabetic Medicine

Volumn 26, Issue 12, 2009, Pages 1262-1268

  Zhou, X H ^a,b,c   Ji, L N ^a,b   Luo, Y Y ^a,b   Zhang, X Y ^a,b   Han, X Y ^a,b   Qiao, Q ^c,d  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b PEKING UNIVERSITY   (China)

^c UNIVERSITY OF HELSINKI   (Finland)

^d NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Diabetes; Glycated haemoglobin; Screening

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHINA; DIABETES MELLITUS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PREVALENCE; ROC CURVE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; URBAN POPULATION;

BIOLOGICAL MARKERS; BODY MASS INDEX; CHINA; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PREVALENCE; SENSITIVITY AND SPECIFICITY;

EID: 70549102505     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2009.02831.x     Document Type: Article

References (25)

1. Jia WP, Pang C, Chen L, Bao YQ, Lu JX, Lu HJ et al. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 2007 50 : 286 292.
2. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997 20 : 537 544.
3. Tuomilehto J, Lindstrom J, Eriksson JG, Valle TT, Hamalainen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001 344 : 1343 1350. (Pubitemid 32378388)
4. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002 346 : 393 403.
5. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008 31 : S55 S60.
6. WHO. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1. Diagnosis and Classification of Diabetes Mellitus (WHO/NCD/NCS/99.2), Geneva : World Health Organization, 1999.
7. 1c measurement improves the detection of type 2 diabetes in high-risk individuals with non-diagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care 2001 24 : 465 471.
8. Eschwege E, Charles MA, Simon D, Thibult N, Balkau B. Reproducibility of the diagnosis of diabetes over a 30-month follow-up: the Paris Prospective Study. Diabetes Care 2001 24 : 1941 1944.
9. Gomez-Perez FJ, Aguilar-Salinas CA, Lopez-Alvarenga JC, Perez-Jauregui J, Guillen-Pineda LE, Rull JA. Lack of agreement between the World Health Organization Category of impaired glucose tolerance and the American Diabetes Association category of impaired fasting glucose. Diabetes Care 1998 21 : 1886 1888.
10. 1c as a screening tool for detection of Type 2 diabetes: a systematic review. Diabet Med 2007 24 : 333 343.
11. WHO-International Society of Hypertension. Guidelines for the Management of Hypertension. Guidelines Subcommittee. J Hypertens 1999 17 : 151 183.
12. Akobeng AK. Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007 96 : 644 647.
13. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 1993 39 : 561 577.
14. 1c) in screening for undiagnosed diabetes in the US population. Diabetes Care 2000 23 : 187 191.
15. Colagiuri S, Hussain Z, Zimmet P, Cameron A, Shaw J. Screening for type 2 diabetes and impaired glucose metabolism: the Australian experience. Diabetes Care 2004 27 : 367 371.
16. 1c for diabetes screening in the 1999-2004 NHANES population. Diabetes Care 2007 30 : 2233 2235.
17. 1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care 1998 21 : 1221 1225.
18. 1c for supportive marker to diagnose diabetes mellitus in Japanese subjects. Diabetes Res Clin Pract 2001 53 : 41 45.
19. 1c for cost-effective screening. Diabetes Care 2003 26 : 485 490.
20. Saydah SH, Byrd-Holt D, Harris MI. Projected impact of implementing the results of the diabetes prevention program in the US population. Diabetes Care 2002 25 : 1940 1945.
21. Mannucci E, Ognibene A, Sposato I, Brogi M, Gallori G, Bardini G et al. Fasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose tolerance. Acta Diabetol 2003 40 : 181 186.
22. King H, Zimmet P, Raper LR, Balkau B. The natural history of impaired glucose tolerance in the Micronesian population of Nauru: a six-year follow-up study. Diabetologia 1984 26 : 39 43.
23. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med 1988 319 : 1500 1506.
24. 1c assay in the diagnosis of diabetes. Diabetes Care 2009 32 : 1327 1334.
25. 1c and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabet Med 2009 26 : 115 121.